Ellevest, Inc. Vbi Vaccines Inc Transaction History

Ellevest, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 19, 2021	SELL	$2.8 - $3.72 $2,018 - $2,682	-721 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$2.61 - $4.17 $1,881 - $3,006	721 New	721 $2,000
Q2 2020 Jul 06, 2020	SELL	$0.87 - $3.13 $11 - $40	-13 Closed	0 $0
Q1 2020 Apr 13, 2020	BUY	$0.73 - $1.91 $9 - $24	13 New	13 $0

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.